Cytokinetics Inc (NASDAQ:CYTK)

9.15
Delayed Data
As of May 18
 0.00 / 0.00%
Today’s Change
6.75
Today|||52-Week Range
15.95
+12.27%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 13.00, with a high estimate of 20.00 and a low estimate of 10.00. The median estimate represents a +42.08% increase from the last price of 9.15.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.46
Sales
$7.2M
Reporting Date
Aug 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 17.86%
 
 
 
 
 
 
Growthannually 26.83%
 
 
 
 
 
 

Sales

Growthquarterly 35.82%
 
 
 
 
 
 
Growthannually 86.68%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.